Carolina Pinto-Espinoza

A Methodological Approach Using rAAV Vectors Encoding Nanobody-Based Biologics to Evaluate ARTC2.2 and P2X7 In Vivo

F. Koch-Nolte, O. Boyer, S. Adriouch, 2021, Frontiers in Immunology.

Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano)

F. Koch-Nolte, F. Haag, S. Adriouch, 2020, Frontiers in Oncology.

Current Approaches and Future Perspectives for Nanobodies in Stroke Diagnostic and Therapy

F. Koch-Nolte, Y. Duan, T. Magnus, 2019, Antibodies.

Modulating ion channel function with antibodies and nanobodies.

F. Koch-Nolte, D. van Hoorick, Carolina Pinto-Espinoza, 2018, Current opinion in immunology.

P2X7 is expressed on human innate‐like T lymphocytes and mediates susceptibility to ATP‐induced cell death

F. Koch-Nolte, A. Guse, T. Magnus, 2022, European journal of immunology.

Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVs

A. Nicke, N. Schwarz, F. Koch-Nolte, 2022, Frontiers in Pharmacology.

Novel biologics targeting the P2X7 ion channel.

S. Menzel, N. Schwarz, F. Koch-Nolte, 2019, Current opinion in pharmacology.

Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in mice

S. Adriouch, H. Gondé, Mélanie Demeules, 2024, Journal of nanobiotechnology.